July 28, 2025
Drug repurposing fast-tracks treatments for epilepsy
March 24, 2025
Brain organoids grown from human cells offer insights into rare epilepsies.
November 20, 2024
To really move the needle on SUDEP research, we need to bridge two key topics: advancing our understanding of SUDEP risk through existing data and leveraging that knowledge to develop tools that help individuals and healthcare providers better understand and communicate risk.
October 09, 2024
A humble side project has developed into a potential curative treatment on the cusp of human clinical trials, thanks to CURE Epilepsy funding.
July 08, 2024
Captain Jack Somers was familiar with operating in stealth mode, hidden from enemies. But unbeknownst to him, similarly covert changes were taking root in his brain after a particularly close grenade blast experienced in 2010 while serving overseas.
March 11, 2024
These genes included some known FCD genes, as well as six new genes that could also contribute to FCD.
December 01, 2023
CURE Epilepsy has long been leading the charge in funding research on seizure-related biomarkers and is committed to advancing this research as it will have the potential to improve outcomes for people with epilepsy by identifying, for example, who may be at risk for epilepsy after a stroke to who may be at risk for epilepsy following a brain injury to who may not respond to antiseizure medications.
October 19, 2023
CURE Epilepsy has been a leader in driving awareness and research on SUDEP since 2004, when it started the first private research program to investigate SUDEP and its prevention.
October 06, 2023
Studying brain activity to identify biological signals (biomarkers) may help predict who will develop epilepsy following a brain injury.
